New Delhi : Country’s drug controller General of India (DCGI) has written a strongly worded letter to Rogerio Gaspar, Director, Regulation and Prequalification, WHO informing that all control samples of the products have been found to be complying with specifications. Government’s Central Drug Laboratory (CDL) which conducted quality tests on the samples lifted from Maiden pharmaceuticals – the Sonepat-based company which has been in the dock for allegedly causing deaths of children in Gambia has found the products to be complying with specifications, putting the onus on World Health Organisation (WHO) for “prematurely” blaming an Indian company for the deaths without any “independent verification”.
DGCI finds no violation in Maiden Pharma case as claimed by WHO
Date:
More like thisRelated
Harmony Foundation Hails ‘Reverse Baraat’ Trend as Symbol of Women Empowerment, Calls It a Stand Against Domestic Abuse
Reverse Baraat | Fathers Welcoming Daughters Home Breaks Society's...
25 Women Rescued From Fake Dance Academy: Harmony Foundation Praises Maha Police
A major human trafficking and prostitution racket operating under...
Shrikant Shinde Demands 15-Coach Local Trains, Marathi Literature Stalls at Railway Stations
Kalyan MP Shrikant Shinde on Tuesday raised significant demands...
Thane Deputy Mayor Flags Dangerous Speed Breakers, Urges Citywide Audit
In Thane, concerns over unauthorized and dangerous speed breakers...